Global Circulating Biomarker Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
The global Circulating Biomarker market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
This report offers an overview of the market trends, drivers, and barriers with respect to the Circulating Biomarker market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Circulating Biomarker market by By Cancer Type, By Product, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Circulating Biomarker market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
This report focuses Global market, it covers details as following:
Key Players
Circulating Biomarker Market, by Cancer Type
This report offers an overview of the market trends, drivers, and barriers with respect to the Circulating Biomarker market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Circulating Biomarker market by By Cancer Type, By Product, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Circulating Biomarker market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
This report focuses Global market, it covers details as following:
Key Players
- Biocept Inc (U.S.)
- Myriad Genetics (U.S.)
- QIAGEN (Netherlands)
- Roche (Switzerland)
- Bio-Rad Laboratories (U.S.)
- Trovagene (U.S.)
- Guardant Health (U.S.)
- Janssen Diagnostics (U.S.)
- Fraunhofer-Gesellschaft (Germany)
- MDxHealth SA (U.S.)
- North America
- United States
- Canada
- Latin America
- Mexico
- Brazil
- Argentina
- Others
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherland
- Others
- Asia & Pacific
- China
- Japan
- India
- Korea
- Australia
- Southeast Asia
- Indonesia
- Thailand
- Philippines
- Vietnam
- Singapore
- Malaysia
- Others
- Africa & Middle East
- South Africa
- Egypt
- Turkey
- Saudi Arabia
- Iran
- Others
Circulating Biomarker Market, by Cancer Type
- Lung
- Breast
- Colorectal
- Prostate
- Circulating Tumor Cells
- Circulating Tumor DNA
- Reference Laboratory
- Research Centers
CHAPTER ONE METHODOLOGY AND DATA SOURCE
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
CHAPTER TWO CIRCULATING BIOMARKER MARKET OVERVIEW
2.1 Market Coverage
2.2 Global Circulating Biomarker Market Sales Volume Revenue and Price 2012-2017
CHAPTER THREE CIRCULATING BIOMARKER BY KEY PLAYERS 2012-2017
3.1 Global Circulating Biomarker Sales Volume Market Share by Key Players 2012-2017
3.2 Global Circulating Biomarker Revenue Share by Key Players 2012-2017
3.3 Global Key Players Circulating Biomarker Key Product Model and Market Performance
3.4 Global Key Players Circulating Biomarker Key Target Consumers and Market Performance
CHAPTER FOUR CIRCULATING BIOMARKER BY REGIONS 2012-2017
4.1 Global Circulating Biomarker Sales Market Share by Regions 2012-2017
4.2 Global Circulating Biomarker Revenue Market Share by Regions 2012-2017
4.3 Global Circulating Biomarker Price by Regions 2012-2017
4.4 North America
4.4.1 United States
4.4.2 Canada
4.5 Latin America
4.5.1 Mexico
4.5.2 Brazil
4.5.3 Argentina
4.5.4 Others in Latin America
4.6 Europe
4.6.1 Germany
4.6.2 United Kingdom
4.6.3 France
4.6.4 Italy
4.6.5 Spain
4.6.6 Russia
4.6.7 Netherland
4.6.8 Others in Europe
4.7 Asia & Pacific
4.7.1 China
4.7.2 Japan
4.7.3 India
4.7.4 Korea
4.7.5 Australia
4.7.6 Southeast Asia
4.7.6.1 Indonesia
4.7.6.2 Thailand
4.7.6.3 Philippines
4.7.6.4 Vietnam
4.7.6.5 Singapore
4.7.6.6 Malaysia
4.7.6.7 Others in Southeast Asia
4.8 Africa & Middle East
4.8.1 South Africa
4.8.2 Egypt
4.8.3 Turkey
4.8.4 Saudi Arabia
4.8.5 Iran
4.8.6 Others in Africa & Middle East
CHAPTER FIVE CIRCULATING BIOMARKER MARKET BY PRODUCT TYPES
5.1 Circulating Biomarker, by Cancer Type 2012-2017
5.1.1 Global Circulating Biomarker Sales Market Share by Cancer Type 2012-2017
5.1.2 Global Circulating Biomarker Revenue Market Share by Cancer Type 2012-2017
5.1.3 Global Circulating Biomarker Price by Cancer Type 2012-2017
5.1.4 Lung
5.1.5 Breast
5.1.6 Colorectal
5.1.7 Prostate
5.2 Circulating Biomarker, by Product 2012-2017
5.2.1 Global Circulating Biomarker Sales Market Share by Product 2012-2017
5.2.2 Global Circulating Biomarker Revenue Market Share by Product 2012-2017
5.2.3 Global Circulating Biomarker Price by Product 2012-2017
5.2.4 Circulating Tumor Cells
5.2.5 Circulating Tumor DNA
CHAPTER SIX GLOBAL KEY PLAYERS PROFILE
6.1 Biocept Inc (U.S.)
6.1.1 Biocept Inc (U.S.) Company Details and Competitors
6.1.2 Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
6.1.3 Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.1.4 Biocept Inc (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.2 Myriad Genetics (U.S.)
6.2.1 Myriad Genetics (U.S.) Company Details and Competitors
6.2.2 Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
6.2.3 Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.2.4 Myriad Genetics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.3 QIAGEN (Netherlands)
6.3.1 QIAGEN (Netherlands) Company Details and Competitors
6.3.2 QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
6.3.3 QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
6.3.4 QIAGEN (Netherlands) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.4 Roche (Switzerland)
6.4.1 Roche (Switzerland) Company Details and Competitors
6.4.2 Roche (Switzerland) Key Circulating Biomarker Models and Performance
6.4.3 Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
6.4.4 Roche (Switzerland) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.5 Bio-Rad Laboratories (U.S.)
6.5.1 Bio-Rad Laboratories (U.S.) Company Details and Competitors
6.5.2 Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
6.5.3 Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.5.4 Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.6 Trovagene (U.S.)
6.6.1 Trovagene (U.S.) Company Details and Competitors
6.6.2 Trovagene (U.S.) Key Circulating Biomarker Models and Performance
6.6.3 Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.6.4 Trovagene (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.7 Guardant Health (U.S.)
6.7.1 Guardant Health (U.S.) Company Details and Competitors
6.7.2 Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
6.7.3 Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.7.4 Guardant Health (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.8 Janssen Diagnostics (U.S.)
6.8.1 Janssen Diagnostics (U.S.) Company Details and Competitors
6.8.2 Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
6.8.3 Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.8.4 Janssen Diagnostics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.9 Fraunhofer-Gesellschaft (Germany)
6.9.1 Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
6.9.2 Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
6.9.3 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
6.9.4 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.10 MDxHealth SA (U.S.)
6.10.1 MDxHealth SA (U.S.) Company Details and Competitors
6.10.2 MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
6.10.3 MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.10.4 MDxHealth SA (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
CHAPTER SEVEN CIRCULATING BIOMARKER BY APPLIANCE 2012-2017
7.1 Global Circulating Biomarker Sales Market Share by Appliance 2012-2017
7.2 Reference Laboratory
7.3 Research Centers
7.4 Consuming Habit and Preference
CHAPTER EIGHT INDUSTRY CHAIN AND SUPPLY CHAIN
8.1 Circulating Biomarker Industry Chain Structure
8.1.1 R&D
8.1.2 Raw Materials (Components)
8.1.3 Manufacturing Plants
8.1.4 Regional Trading (Import Export and Local Sales)
8.1.5 Online Sales Channel
8.1.6 Offline Channel
8.1.7 End Users
8.2 Circulating Biomarker Manufacturing
8.2.1 Key Components
8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment
CHAPTER NINE GLOBAL CIRCULATING BIOMARKER MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
9.1 Global Circulating Biomarker Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
9.2 Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
9.3 Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
9.4 Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
9.5 Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
CHAPTER TEN DEVELOPMENT TREND AND RESEARCH CONCLUSION
10.1 Development Trend
10.2 Research Conclusion
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
CHAPTER TWO CIRCULATING BIOMARKER MARKET OVERVIEW
2.1 Market Coverage
2.2 Global Circulating Biomarker Market Sales Volume Revenue and Price 2012-2017
CHAPTER THREE CIRCULATING BIOMARKER BY KEY PLAYERS 2012-2017
3.1 Global Circulating Biomarker Sales Volume Market Share by Key Players 2012-2017
3.2 Global Circulating Biomarker Revenue Share by Key Players 2012-2017
3.3 Global Key Players Circulating Biomarker Key Product Model and Market Performance
3.4 Global Key Players Circulating Biomarker Key Target Consumers and Market Performance
CHAPTER FOUR CIRCULATING BIOMARKER BY REGIONS 2012-2017
4.1 Global Circulating Biomarker Sales Market Share by Regions 2012-2017
4.2 Global Circulating Biomarker Revenue Market Share by Regions 2012-2017
4.3 Global Circulating Biomarker Price by Regions 2012-2017
4.4 North America
4.4.1 United States
4.4.2 Canada
4.5 Latin America
4.5.1 Mexico
4.5.2 Brazil
4.5.3 Argentina
4.5.4 Others in Latin America
4.6 Europe
4.6.1 Germany
4.6.2 United Kingdom
4.6.3 France
4.6.4 Italy
4.6.5 Spain
4.6.6 Russia
4.6.7 Netherland
4.6.8 Others in Europe
4.7 Asia & Pacific
4.7.1 China
4.7.2 Japan
4.7.3 India
4.7.4 Korea
4.7.5 Australia
4.7.6 Southeast Asia
4.7.6.1 Indonesia
4.7.6.2 Thailand
4.7.6.3 Philippines
4.7.6.4 Vietnam
4.7.6.5 Singapore
4.7.6.6 Malaysia
4.7.6.7 Others in Southeast Asia
4.8 Africa & Middle East
4.8.1 South Africa
4.8.2 Egypt
4.8.3 Turkey
4.8.4 Saudi Arabia
4.8.5 Iran
4.8.6 Others in Africa & Middle East
CHAPTER FIVE CIRCULATING BIOMARKER MARKET BY PRODUCT TYPES
5.1 Circulating Biomarker, by Cancer Type 2012-2017
5.1.1 Global Circulating Biomarker Sales Market Share by Cancer Type 2012-2017
5.1.2 Global Circulating Biomarker Revenue Market Share by Cancer Type 2012-2017
5.1.3 Global Circulating Biomarker Price by Cancer Type 2012-2017
5.1.4 Lung
5.1.5 Breast
5.1.6 Colorectal
5.1.7 Prostate
5.2 Circulating Biomarker, by Product 2012-2017
5.2.1 Global Circulating Biomarker Sales Market Share by Product 2012-2017
5.2.2 Global Circulating Biomarker Revenue Market Share by Product 2012-2017
5.2.3 Global Circulating Biomarker Price by Product 2012-2017
5.2.4 Circulating Tumor Cells
5.2.5 Circulating Tumor DNA
CHAPTER SIX GLOBAL KEY PLAYERS PROFILE
6.1 Biocept Inc (U.S.)
6.1.1 Biocept Inc (U.S.) Company Details and Competitors
6.1.2 Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
6.1.3 Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.1.4 Biocept Inc (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.2 Myriad Genetics (U.S.)
6.2.1 Myriad Genetics (U.S.) Company Details and Competitors
6.2.2 Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
6.2.3 Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.2.4 Myriad Genetics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.3 QIAGEN (Netherlands)
6.3.1 QIAGEN (Netherlands) Company Details and Competitors
6.3.2 QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
6.3.3 QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
6.3.4 QIAGEN (Netherlands) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.4 Roche (Switzerland)
6.4.1 Roche (Switzerland) Company Details and Competitors
6.4.2 Roche (Switzerland) Key Circulating Biomarker Models and Performance
6.4.3 Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
6.4.4 Roche (Switzerland) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.5 Bio-Rad Laboratories (U.S.)
6.5.1 Bio-Rad Laboratories (U.S.) Company Details and Competitors
6.5.2 Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
6.5.3 Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.5.4 Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.6 Trovagene (U.S.)
6.6.1 Trovagene (U.S.) Company Details and Competitors
6.6.2 Trovagene (U.S.) Key Circulating Biomarker Models and Performance
6.6.3 Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.6.4 Trovagene (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.7 Guardant Health (U.S.)
6.7.1 Guardant Health (U.S.) Company Details and Competitors
6.7.2 Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
6.7.3 Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.7.4 Guardant Health (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.8 Janssen Diagnostics (U.S.)
6.8.1 Janssen Diagnostics (U.S.) Company Details and Competitors
6.8.2 Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
6.8.3 Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.8.4 Janssen Diagnostics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.9 Fraunhofer-Gesellschaft (Germany)
6.9.1 Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
6.9.2 Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
6.9.3 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
6.9.4 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
6.10 MDxHealth SA (U.S.)
6.10.1 MDxHealth SA (U.S.) Company Details and Competitors
6.10.2 MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
6.10.3 MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
6.10.4 MDxHealth SA (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
CHAPTER SEVEN CIRCULATING BIOMARKER BY APPLIANCE 2012-2017
7.1 Global Circulating Biomarker Sales Market Share by Appliance 2012-2017
7.2 Reference Laboratory
7.3 Research Centers
7.4 Consuming Habit and Preference
CHAPTER EIGHT INDUSTRY CHAIN AND SUPPLY CHAIN
8.1 Circulating Biomarker Industry Chain Structure
8.1.1 R&D
8.1.2 Raw Materials (Components)
8.1.3 Manufacturing Plants
8.1.4 Regional Trading (Import Export and Local Sales)
8.1.5 Online Sales Channel
8.1.6 Offline Channel
8.1.7 End Users
8.2 Circulating Biomarker Manufacturing
8.2.1 Key Components
8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment
CHAPTER NINE GLOBAL CIRCULATING BIOMARKER MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
9.1 Global Circulating Biomarker Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
9.2 Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
9.3 Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
9.4 Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
9.5 Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
CHAPTER TEN DEVELOPMENT TREND AND RESEARCH CONCLUSION
10.1 Development Trend
10.2 Research Conclusion
LIST OF TABLES AND FIGURES
Table Global Circulating Biomarker Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Circulating Biomarker Sales Volume (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Table Global Circulating Biomarker Sales Volume Market Share by Key Players (2012-2017)
Figure Global Circulating Biomarker Sales Volume Market Share by Key Players 2016
Figure Global Circulating Biomarker Sales Volume Market Share by Key Players 2017
Table Global Circulating Biomarker Revenue (Million USD) by Key Players (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Key Players (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Key Players 2016
Figure Global Circulating Biomarker Revenue Market Share by Key Players 2017
Table Global Key Players Key Product Model and Market Performance
Table Global Key Players Key Target Consumers and Market Performance
Table Global Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Global Circulating Biomarker Sales Share by Regions (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Regions in 2016
Figure Global Circulating Biomarker Sales Market Share by Regions in 2017
Table Global Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Regions (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2016
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2017
Table Global Circulating Biomarker Price (USD/Unit) by Regions (2012-2017)
Table North America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table North America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table North America Circulating Biomarker Sales Volume (K Units) by Key Players 2012-2017
Figure North America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Latin America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Latin America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Latin America Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Latin America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Europe Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Europe Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Europe Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Europe Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Asia & Pacific Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Asia & Pacific Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Asia & Pacific Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Asia & Pacific Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Africa & Middle East Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Africa & Middle East Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Africa & Middle East Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Africa & Middle East Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
Table Top Players of Lung Circulating Biomarker Products List
Figure Global Lung Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Breast Circulating Biomarker Products List
Figure Global Breast Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Colorectal Circulating Biomarker Products List
Figure Global Colorectal Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Prostate Circulating Biomarker Products List
Figure Global Prostate Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Product (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Product in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Product (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Product in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
Table Top Players of Circulating Tumor Cells Circulating Biomarker Products List
Figure Global Circulating Tumor Cells Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Circulating Tumor DNA Circulating Biomarker Products List
Figure Global Circulating Tumor DNA Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by (2012-2017)
Table Global Circulating Biomarker Sales Market Share by (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by in 2016
Table Global Circulating Biomarker Revenue (Million USD) by (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by in 2016
Table Global Circulating Biomarker Price (USD/Unit) by (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by (2012-2017)
Table Global Circulating Biomarker Sales Market Share by (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by in 2016
Table Global Circulating Biomarker Revenue (Million USD) by (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by in 2016
Table Global Circulating Biomarker Price (USD/Unit) by (2012-2017)
Table Biocept Inc (U.S.) Company Details and Competitors
Table Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
Table Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Biocept Inc (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Myriad Genetics (U.S.) Company Details and Competitors
Table Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
Table Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Myriad Genetics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table QIAGEN (Netherlands) Company Details and Competitors
Table QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
Table QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
Table QIAGEN (Netherlands) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Roche (Switzerland) Company Details and Competitors
Table Roche (Switzerland) Key Circulating Biomarker Models and Performance
Table Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
Table Roche (Switzerland) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Bio-Rad Laboratories (U.S.) Company Details and Competitors
Table Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Trovagene (U.S.) Company Details and Competitors
Table Trovagene (U.S.) Key Circulating Biomarker Models and Performance
Table Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Trovagene (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Guardant Health (U.S.) Company Details and Competitors
Table Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
Table Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Guardant Health (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Janssen Diagnostics (U.S.) Company Details and Competitors
Table Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
Table Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Janssen Diagnostics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
Table Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table MDxHealth SA (U.S.) Company Details and Competitors
Table MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
Table MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table MDxHealth SA (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Appliance (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Appliance (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Appliance in 2016
Figure Global Reference Laboratory Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure Global Research Centers Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure Global Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Cancer Type in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Product in 2022
Table Global Circulating Biomarker Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Circulating Biomarker Sales Volume (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Table Global Circulating Biomarker Sales Volume Market Share by Key Players (2012-2017)
Figure Global Circulating Biomarker Sales Volume Market Share by Key Players 2016
Figure Global Circulating Biomarker Sales Volume Market Share by Key Players 2017
Table Global Circulating Biomarker Revenue (Million USD) by Key Players (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Key Players (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Key Players 2016
Figure Global Circulating Biomarker Revenue Market Share by Key Players 2017
Table Global Key Players Key Product Model and Market Performance
Table Global Key Players Key Target Consumers and Market Performance
Table Global Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Global Circulating Biomarker Sales Share by Regions (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Regions in 2016
Figure Global Circulating Biomarker Sales Market Share by Regions in 2017
Table Global Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Regions (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2016
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2017
Table Global Circulating Biomarker Price (USD/Unit) by Regions (2012-2017)
Table North America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table North America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table North America Circulating Biomarker Sales Volume (K Units) by Key Players 2012-2017
Figure North America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Latin America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Latin America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Latin America Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Latin America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Europe Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Europe Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Europe Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Europe Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Asia & Pacific Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Asia & Pacific Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Asia & Pacific Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Asia & Pacific Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Africa & Middle East Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Africa & Middle East Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Table Africa & Middle East Circulating Biomarker Sales Volume (K Units) by Key Players (2012-2017)
Figure Africa & Middle East Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
Table Top Players of Lung Circulating Biomarker Products List
Figure Global Lung Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Breast Circulating Biomarker Products List
Figure Global Breast Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Colorectal Circulating Biomarker Products List
Figure Global Colorectal Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Prostate Circulating Biomarker Products List
Figure Global Prostate Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Product (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Product in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Product (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Product in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
Table Top Players of Circulating Tumor Cells Circulating Biomarker Products List
Figure Global Circulating Tumor Cells Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Players of Circulating Tumor DNA Circulating Biomarker Products List
Figure Global Circulating Tumor DNA Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by (2012-2017)
Table Global Circulating Biomarker Sales Market Share by (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by in 2016
Table Global Circulating Biomarker Revenue (Million USD) by (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by in 2016
Table Global Circulating Biomarker Price (USD/Unit) by (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by (2012-2017)
Table Global Circulating Biomarker Sales Market Share by (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by in 2016
Table Global Circulating Biomarker Revenue (Million USD) by (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by in 2016
Table Global Circulating Biomarker Price (USD/Unit) by (2012-2017)
Table Biocept Inc (U.S.) Company Details and Competitors
Table Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
Table Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Biocept Inc (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Myriad Genetics (U.S.) Company Details and Competitors
Table Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
Table Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Myriad Genetics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table QIAGEN (Netherlands) Company Details and Competitors
Table QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
Table QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
Table QIAGEN (Netherlands) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Roche (Switzerland) Company Details and Competitors
Table Roche (Switzerland) Key Circulating Biomarker Models and Performance
Table Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
Table Roche (Switzerland) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Bio-Rad Laboratories (U.S.) Company Details and Competitors
Table Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Trovagene (U.S.) Company Details and Competitors
Table Trovagene (U.S.) Key Circulating Biomarker Models and Performance
Table Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Trovagene (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Guardant Health (U.S.) Company Details and Competitors
Table Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
Table Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Guardant Health (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Janssen Diagnostics (U.S.) Company Details and Competitors
Table Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
Table Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Janssen Diagnostics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
Table Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table MDxHealth SA (U.S.) Company Details and Competitors
Table MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
Table MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table MDxHealth SA (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Appliance (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Appliance (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Appliance in 2016
Figure Global Reference Laboratory Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure Global Research Centers Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure Global Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Cancer Type in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Product in 2022
